9 terminated. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Terminated 9 |
Follow Dry Eye: new trials by email Literature Review of Dry Eye trials Research Report on Dry Eye
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Performance of Systane PRO Versus Refresh Optive Mega-3 Systane PRO, Refresh Optive MEGA-3 - Dry Eye | Phase 4 | Terminated | Scripps Poway Eyecare and Optometry | 20 | 2025-05-15 | 2026-04-13 |
| A Study Evaluating the Safety of the Nasal Pump Tyrvaya Nasal Pump - Dry Eye, Kerato Conjunctivitis Sicca | Phase 4 | Terminated | Oyster Point Pharma, Inc. | 5 | 2024-02-21 | 2025-05-02 |
| Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort HydroEye® - Dry Eye, Contact Lens Complication | Phase 4 | Terminated | University of Alabama at Birmingham | 31 | 2022-09-16 | 2025-03-06 |
| Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye Sustained Release Dexamethasone, 0.4 mg, E-Caprolactone-L-Lactide copolymer (PCL) punctal plug - Dry Eye | Phase 4 | Terminated | Johns Hopkins University | 77 | 2021-03-16 | 2024-03-15 |
| Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED) Dextenza (IDI) (Sustained Release Dexamethasone), (0.4 mg), ProLong™ collagen plugs - Dry Eye | Phase 4 | Terminated | Tufts Medical Center | 54 | 2020-09-04 | 2025-01-15 |
| Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease iLux® system - Dry Eye | Phase 4 | Terminated | University of Waterloo | 28 | 2019-11-15 | 2023-05-16 |
| Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests Preservative-free Refresh Optive Advanced Lubricant Eye Drops - Dry Eye | Phase 4 | Terminated | Tufts Medical Center | 36 | 2019-10-03 | 2025-09-22 |
| Azithromycin for Meibomian Gland Disease Azithromycin Oral Product, Placebo Oral - Dry Eye, Neuropathic Eye Pain | Phase 4 | Terminated | University of California, San Francisco | 2 | 2019-09-01 | 2025-08-06 |
| The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye Cyclosporine A 0.05%, Arificial Tear - Dry Eye | Phase 4 | Terminated | Massachusetts Eye and Ear Infirmary | 8 | 2007-08-01 | 2017-03-28 |
Dry Eye Syndromes (9) · Anxiety Disorders (1) · Depression (1) · Graft vs Host Disease (1)
Eye Diseases (9) · Lacrimal Apparatus Diseases (9) · Behavior (1) · Behavioral Symptoms (1) · Immune System Diseases (1) · Mental Disorders (1)
Calcium Dobesilate (2) · Azithromycin (1) · Cyclosporins (1) · Lubricant Eye Drops (1) · Punctal Plugs (1)
Tufts Medical Center (2) · Johns Hopkins University (1) · Massachusetts Eye and Ear Infirmary (1) · Oyster Point Pharma, Inc. (1) · Scripps Poway Eyecare and Optometry (1) · University of Alabama at Birmingham (1) · University of California, San Francisco (1) · University of Waterloo (1)
United States (8) · Canada (1)
Esen Akpek, MD (1) · Jay Mashouf, OD (1) · Julie Schallhorn, MD, MS (1) · Kelly K Nichols, OD, PhD (1) · Lyndon Jones, PhD, FCOptom (1) · Pedram Hamrah, MD (1) · Reza Dana, M.D. (1) · Stephanie Cox, OD (1) · Thuy Doan, MD, PhD (1)